Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.380
+0.035 (2.60%)
Aug 13, 2026, 4:37 PM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 61.44 million as of August 13, 2026. Its market cap has decreased by -41.48% in one year.
Market Cap
61.44M
Enterprise Value
45.54M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.38
ChartMarket Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 61.44M, a decrease of -57.45%. That is a compound annual growth rate of -15.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 61.44M | -29.13% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 134.48M |
| Annexin Pharmaceuticals AB | 89.30M |
| OncoZenge AB | 80.78M |
| Spago Nanomedical AB | 76.74M |
| Ascelia Pharma AB | 76.12M |
| AcouSort AB | 73.02M |
| Disruptive Pharma AB | 61.80M |
| 2cureX AB | 52.32M |